跳至主要内容
临床试验/IRCT201702016388N7
IRCT201702016388N7已完成2 期

Compare the response to treatment in patients with newly diagnosed chronic hepatitis C (genotype ? ) and patients without any response to previous treatments , with combination of sofosbuvir-daklatsvir

Vice Chancellor for Research of Tabriz University of Medical Sciences0 个研究点目标入组 50 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
no limit 至 no limit(—)
性别
All

入选标准

  • People with HCV genotype HCV RNA in a headline above or positive? People who have detectable HCV RNA titers after previous treatment failure and relapse patients.
  • Exclusion criteria: People who sovodak therapy to stop for any reason? People infected with virus (HIV) concurrently? There is no reason other than HCV patients with chronic hepatitis? People with hepatitis B concurrently? People who have undergone liver transplantation recently? People who have low life expectancy? There is no assurance that the cut intravenous drug users inject drugs? Patients who received Amiodarone in the last 6 months? Women who are pregnant or plan to become pregnant or are breastfeeding? Those who have allergies to Lactose (sovodak with Lactose).

排除标准

  • 未提供

研究者

发起方
Vice Chancellor for Research of Tabriz University of Medical Sciences

相似试验